Skip to main content
. 2010 Oct 8;299(6):H2082–H2089. doi: 10.1152/ajpheart.00511.2010

Table 3.

Hemodynamic effects of BAY 60-6583 in A2b AR KO hearts

LVSP, mmHg +dP/dt, mmHg/s −dP/dt, mmHg/s CF, ml/min
Baseline 89 ± 3 3,140 ± 286 −1,983 ± 117 2.5 ± 0.2
100 nM BAY 60-6583 88 ± 3 3,177 ± 294 −1,996 ± 126 2.5 ± 0.2
500 nM BAY 60-6583 88 ± 3 3,184 ± 309 −2,007 ± 117 2.5 ± 0.2
1000 nM BAY 60-6583 90 ± 3 3,321 ± 376 −2,116 ± 163 2.6 ± 0.3

Values are means ± SE. Baseline values were taken before treatment with the A2bAR agonist BAY 60-6583.